Determinants of Progression and Regression of Subclinical Atherosclerosis Over 6 Years
Guiomar Mendieta(Spanish National Centre for Cardiovascular Research), Valentı́n Fuster(Spanish National Centre for Cardiovascular Research), Stuart Pocock(University of London), Borja Ibáñez, Beatriz López‐Melgar(Spanish National Centre for Cardiovascular Research), Antonio Fernández‐Ortíz(Universidad Complutense de Madrid), Héctor Bueno, Vicente Andrés(Spanish National Centre for Cardiovascular Research), Inés García‐Lunar(Spanish National Centre for Cardiovascular Research), Javier Sánchez‐Gonzalez(Philips (Spain)), Andrea Delgado Moreno(Spanish National Centre for Cardiovascular Research), Virginia Mass(Spanish National Centre for Cardiovascular Research), José J. Fuster(Spanish National Centre for Cardiovascular Research), Ruth Owen(Spanish National Centre for Cardiovascular Research), Cristina Pérez-Herreras(Banco Santander (Spain)), Ana García‐Álvarez(Spanish National Centre for Cardiovascular Research)
Cited by 106
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
2024 ESC Guidelines for the management of chronic coronary syndromes
|European Heart Journal|2024|2.3k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k
Strategies for Multivessel Revascularization in Patients with Diabetes
|New England Journal of Medicine|2012|1.9k